Journal
MOVEMENT DISORDERS
Volume 24, Issue 14, Pages 2136-2142Publisher
WILEY
DOI: 10.1002/mds.22767
Keywords
progressive supranuclear palsy; Parkinson's disease; multiple system atrophy; autonomic dysfunction; ambulatory blood pressure
Categories
Funding
- Deutsche Forschungsgemeinschaft [SCHO754/3-1, SCHO754/4-1]
- German Research Council (BMBF) [01GM0644]
- GeNeMove [01GM0603]
- EU [LSHM-CT-2004-503304]
- E-RARE [01GM0807]
- RISCA [01GM0820]
- Volkswagen Foundation [1/80711]
- HSP-Selbsthilfegruppe Deutschland
- Cephalon
- Pfizer
- GSK
- Boehringer/Ingelheim
- Bayer Health Care
- UCB Schwarz Pharma
- TEVA/Lundbeck
- Orion
- Novartis
- Hofmann LaRoche
- Desitin
- Valeant
- Johnson Johnson
Ask authors/readers for more resources
Cardiovascular autonomic dysfunction has frequently been reported in some patients with extrapyramidal syndromes, especially multiple system atrophy (MSA) but also Parkinson's disease (PD). However, there are only few reports on the prevalence of cardiovascular autonomic dysfunction progressive in supranuclear palsy (PSP). Moreover, the relation of detailed cardiovascular testing and easy to assess 24-hour ambulatory blood pressure (BP) is not known. Our study evaluates 24-hour ambulatory BP monitoring in patients with PD, PSP, MSA, and corresponding controls (Con) and relates the findings to the results of comprehensive cardiovascular autonomic testing. Twenty-three patients with PD, 25 patients with PSP, 25 patients with MSA, and 26 corresponding controls were studied by 24-hour ambulatory BP monitoring (ABPM) in comparison to cardiovascular autonomic testing. Patients with PD, PSP, and MSA presented frequently with a pathological nocturnal BP regulation (no decrease or even an increase of nocturnal BP) in comparison to the control group (PD 48%, PSP 40%, MSA 68% vs. Con 8%). In MSA and PD patients, the frequent pathological BP increase during night was closely correlated to orthostatic hypotension. Since loss of nocturnal BP fall is frequent in patients with extrapyramidal syndromes, even if they are free of subjective autonomic dysfunction, we recommend 24-hour ABPM as an easy to perform screening test, especially if detailed autonomic testing is not available. Pathological loss of nocturnal BP fall may account for increased cardiovascular mortality in extrapyramidal syndromes. (C) 2009 Movement Disorder Society
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available